Assets

(As of April 30 of the list year, 000's omitted)

Financial Standing

This year was one of continued success, growth, advancement, and investment in our work and the stomach cancer research we are supporting.

Revenue

(As of April 30 of the list year, 000's omitted)

Expenses

(As of April 30 of the list year, 000's omitted)

FY24 at a Glance

Financial Notes

We received restricted donations specified for operational expenditures, and recorded income and expenses from profitable but low-margin events in FY24 and for FY25. These financial figures are excluded from income and expenses in the calculation of every day operational overhead.

We saw a $5,119 net operating loss for FY24, all related to a significant increase in research program investment, all of which was budgeted for based on savings from prior fiscal years. The organization continues to operate with zero liabilities.

Previous

You Fuel Our Mission